Showing results (181-190 of 514) with videos related to
Sort By:
Pageof 52
Journal of Cellular and Molecular Medicine|August 18, 2018
Telocytes are the physiological counterpart of inflammatory fibroid polyps and PDGFRA-mutant GISTsRiccardo Ricci, Maria Cristina Giustiniani, Marco Gessi, et al.Acta Neuropathologica|December 17, 2013
Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entityAndrey Korshunov, Dominik Sturm, Marina Ryzhova, et al.Neuro-Oncology Advances|June 23, 2022
Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updatesGerrit H Gielen, Joshua N Baugh, Dannis G van Vuurden, et al.Acta Neuropathologica|May 31, 2006
Ganglioglioma arising in a Peutz-Jeghers patient: a case report with molecular implicationsNicoletta Resta, Libero Lauriola, Alfredo Puca, et al.Clinical Rheumatology|January 22, 2025
Residual pain and fatigue are affected by disease perception in rheumatoid arthritis in sustained clinical and ultrasound remissionSimone Perniola, Dario Bruno, Clara Di Mario, et al.Journal of Neuro-Oncology|November 12, 2010
Recurrence in childhood medulloblastomaMonika Warmuth-Metz, Sophia Blashofer, André O von Bueren, et al.The Journal of Molecular Diagnostics : JMD|June 27, 2007
Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysisThomas Mikeska, Christoph Bock, Osman El-Maarri, et al.Journal of Neurosurgery. Pediatrics|January 3, 2015
Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare diseaseCarsten Friedrich, Monika Warmuth-Metz, André O von Bueren, et al.Pediatric Blood & Cancer|December 6, 2021
Combinatorial effects of azacitidine and trametinib on NRAS-mutated melanomaKlara-Maria Hanft, Ebrahem Hamed, Max Kaiser, et al.Neuro-Oncology|March 8, 2012
Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylationHeike Peterziel, Julia Müller, Andreas Danner, et al.Pageof 52